Mutual of America Capital Management LLC Reduces Position in The Clorox Company $CLX

Mutual of America Capital Management LLC lessened its stake in shares of The Clorox Company (NYSE:CLX) by 1.4% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 14,139 shares of the company’s stock after selling 196 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Clorox were worth $1,698,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. American National Bank & Trust lifted its stake in Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after acquiring an additional 89 shares during the period. Ransom Advisory Ltd purchased a new stake in Clorox in the first quarter worth $35,000. GW&K Investment Management LLC lifted its stake in Clorox by 239.1% in the first quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after acquiring an additional 208 shares during the period. Ameritas Advisory Services LLC purchased a new stake in Clorox in the second quarter worth $48,000. Finally, Roble Belko & Company Inc boosted its stake in shares of Clorox by 140.7% during the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company’s stock valued at $53,000 after purchasing an additional 211 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of Clorox stock opened at $116.02 on Monday. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The firm has a market capitalization of $14.13 billion, a P/E ratio of 17.79, a P/E/G ratio of 0.96 and a beta of 0.52. The business has a fifty day simple moving average of $121.18 and a two-hundred day simple moving average of $126.85. The Clorox Company has a 12 month low of $115.83 and a 12 month high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating the consensus estimate of $2.24 by $0.63. The business had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter last year, the firm posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be given a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 4.3%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s payout ratio is currently 76.07%.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of research reports. The Goldman Sachs Group cut their target price on shares of Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a research note on Wednesday, October 1st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 14th. BNP Paribas Exane cut their target price on shares of Clorox from $118.00 to $110.00 and set an “underperform” rating on the stock in a research note on Friday, October 17th. JPMorgan Chase & Co. cut their target price on shares of Clorox from $135.00 to $127.00 and set a “neutral” rating on the stock in a research note on Friday, October 10th. Finally, Citigroup cut their target price on shares of Clorox from $135.00 to $130.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 8th. One analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus price target of $130.20.

Insider Activity

In other news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at $6,711,475.38. The trade was a 21.72% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.63% of the stock is currently owned by corporate insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.